NEW YORK – Christopher Kellner, a neurosurgeon at New York City's Mount Sinai Hospital, is developing RNA and protein biomarker panels aimed at improving detection of aneurysms and the treatment of strokes.
In an initial pilot study, Kellner identified a panel of eight plasma proteins that could prove useful for detecting aneurysms in asymptomatic patients. He has applied for a patent covering these markers and is now applying for funding from the National Institutes of Health to follow up these findings with studies in larger cohorts.